What are the active ingredients in gelatide and is there clinical evidence supporting them?

1. What Gelatide’s maker says is in the bottle

The official Gelatide sales page lists cayenne pepper extract, green tea extract, caffeine, wheat fiber, chromium picolinate, ginger extract and L‑Carnitine tartrate as the formulation’s components and frames each as “selected for its potential weight management benefits” ^[1]. That product page is the sole source in the provided set that identifies Gelatide’s ingredients by name ^[1].

2. Ingredient-by-ingredient: what these compounds are commonly claimed to do

Public-facing claims on the Gelatide page attribute metabolic or appetite effects to the mix—stimulant and thermogenic作用 for caffeine and cayenne, metabolic support for L‑Carnitine, blood‑sugar modulation for chromium picolinate, and digestive fiber benefits from wheat fiber ^[1]. These are marketing descriptions on the product site; the provided materials do not include peer‑reviewed trials testing these individual claims within Gelatide’s formula ^[1].

3. Evidence gap: no brand‑level clinical trials found in the supplied reporting

Search results supplied here do not show randomized controlled trials, ClinicalTrials.gov registrations, or peer‑reviewed papers that test Gelatide as a branded supplement ^[2]. The available clinical‑trial links and industry reporting focus heavily on prescription GLP‑1 and other pharmaceutical weight‑loss agents rather than over‑the‑counter supplements like Gelatide ^{[2] [3] [4] [5]}.

4. How to interpret ingredient claims against the broader scientific context

Many supplements repackage ingredients that each have limited or mixed evidence in isolation; commercial softgel delivery platforms (discussed by gelatin ingredient suppliers) make it technically straightforward to deliver such actives but do not substitute for efficacy trials ^{[6] [7]}. The sources here describe gelatin and softgel technologies used to release active ingredients reliably but do not provide efficacy data for Gelatide’s ingredient mix ^{[6] [7]}.

5. Competing narratives and potential agendas to watch

The Gelatide site is a commercial marketing channel and emphasizes user experience and recommended purchases; that introduces a sales incentive to highlight benefits without publishing clinical data ^[1]. By contrast, the clinical‑trial coverage in the provided sources centers on rigorously tested prescription agents (GLP‑1 agonists such as semaglutide and tirzepatide) and large randomized trials, illustrating the difference between regulatory drug development and dietary‑supplement marketing ^{[3] [4] [5]}.

6. What the provided sources do document about rigorous weight‑loss research

The supplied clinical‑trial and industry coverage shows intense, recent trial activity for GLP‑1 receptor agonists with well‑documented randomized trials and regulatory labeling updates—an explicit contrast to the absence of brand‑level supplement trials in this dataset ^{[3] [4] [5]}. This illustrates that strong clinical evidence for substantial, durable weight loss typically comes from large, controlled drug trials rather than single‑site supplement claims ^{[4] [5]}.

7. Practical takeaways and how to follow up responsibly

If you want evidence that Gelatide’s specific formulation works, the supplied sources do not provide randomized, peer‑reviewed trials or ClinicalTrials.gov entries for the product ^[2]. To move beyond marketing claims, look for: published RCTs testing Gelatide as sold, ClinicalTrials.gov registrations for the brand, or independent meta‑analyses on the exact ingredient combinations—none of which appear in the current sources ^{[2] [1]}.

Limitations: this analysis uses only the documents you supplied. Available sources do not mention independent clinical trials of Gelatide and do not provide peer‑reviewed efficacy data for the branded product; they do, however, document the product’s ingredient list ^[1] and broader industry context around softgel delivery and pharmaceutical obesity trials (p1_s3; ^[3]–p2_s4).